Expression levels of other exploratory biomarkers including plasma VEGF, PBMC phospho-Smad, tumor cell TGFβ and its receptors were examined, but could not be correlated to tumor characteristics or clinical outcome. The gene discussed is VEGFA; the disease is neoplasm.